1. Clinical pharmacology of cyclophosphamide;Bagley;Cancer Res,1973
2. The morphological classification of acute lymphoblastic leukaemia: Concordance among observers and clinical correlations;Bennett;Br J Haematol,1981
3. Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190, 000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148);Beran;Clin Cancer Res,1998
4. The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia;Cortes;Blood,1995
5. Activity of an abl specific tyrosine kinase inhibitor in patients with BCR-ABL positive acute leukemia, including chronic myelogenous leukemia in blast crisis [abstract 3082];Druker;Blood,1999